• Ownership

Mark G. Foletta - Insider Trading & Ownership

Entity
Individual
Location
Amylin Pharmaceuticals Inc, 9360 Towne Centre Dr, San Diego, CA
Summary
The estimated net worth of Mark G. Foletta is at least $7.71M dollars as of March 14, 2025. Mark G. Foletta is the Director of DEXCOM INC and owns shares of DEXCOM INC (DXCM) stock worth about $6.96M. Mark G. Foletta is the Director of AMN HEALTHCARE SERVICES INC and owns shares of AMN HEALTHCARE SERVICES INC (AMN) stock worth about $754K.
All Insider Reports
All Insider Reports

Ownership of Mark G. Foletta

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DXCM DEXCOM INC Director $6.96M -$702K -9.16% Jun 17, 2024
AMN AMN HEALTHCARE SERVICES INC Director $754K Apr 19, 2024
ENTA ENANTA PHARMACEUTICALS INC Director Mar 13, 2025

Insider Transactions Reported by Mark G. Foletta:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.